Strategies to optimize the use of currently available lung donors

Journal of Heart and Lung Transplantation

Volumn 23, Issue 10, 2004, Pages 1127-1134

  De Perrot, Marc ^a   Snell, Gregory I ^b   Babcock, Wayne D ^c   Meyers, Bryan F ^d   Patterson, Glenda ^e   Hodges, Tony N ^f   Keshavjee, Shaf ^a,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b ALFRED HOSPITAL   (Australia)

^c OneLegacy Transplant Donor Network   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF MISSISSIPPI   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ARGIPRESSIN; DOPAMINE; GLUCOSE; INSULIN; LIOTHYRONINE; METHYLPREDNISOLONE; NORADRENALIN; SODIUM CHLORIDE; VASOPRESSIN;

BRAIN DEATH; BRONCHOSCOPY; CENTRAL VENOUS PRESSURE; CLINICAL PROTOCOL; DIABETES INSIPIDUS; HEMODYNAMIC MONITORING; HORMONAL THERAPY; HYPERNATREMIA; HYPOTENSION; LIVING DONOR; LUNG CAPILLARY PRESSURE; LUNG LAVAGE; LUNG TRANSPLANTATION; OPERATING ROOM; ORGAN DONOR; PATIENT CARE; PRIORITY JOURNAL; PUS; REVIEW; THORAX RADIOGRAPHY;

ALGORITHMS; BRAIN DEATH; HEMODYNAMIC PROCESSES; HUMANS; LUNG TRANSPLANTATION; ORGAN PRESERVATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; WAITING LISTS;

EID: 5144224774     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.09.010     Document Type: Review

References (45)

1. Hertz M., Taylor D., Trulock E., et al. The registry of the International Society for Heart and lung Transplantation Nineteenth official report - 2002. J Heart Lung Transplant. 21:2002;950
2. Fisher A.J., Dark J.H., Corris P.A. Improving donor lung evaluation A new approach to increase organ supply for lung transplantation. Thorax. 53:1998;818-820
3. Cohen R.G., Starnes V.A. Living donor lung transplantation. World J Surg. 25:2001;244-250
4. Steen S., Sjoberg T., Pierre L., Liao Q., Eriksson L., Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet. 357:2001;825-829
5. Ware L.B., Wang Y., Fang X., et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet. 360:2002;619-620
6. Sundaresan S., Semenkovich J., Ochoa L., et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg. 109:1995;1075-1079
7. Bhorade S.M., Vigneswaran W., McCabe M.A., Garrity E.R. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 19:2000;1199-1204
8. Gabbay E., Williams T.J., Griffiths A.P., et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med. 160:1999;265-271
9. Lucas B.A., Vaughn W.K., Spees E.K., Sanfilippo F. Identification of donor factors predisposing to high discard rates of cadaver kidneys and increased graft loss within one year posttransplantation - SEOPF 1977-1982. South-Eastern Organ Procurement Foundation. Transplantation. 43:1987;253-258
10. Busuttil R.W., Goldstein L.I., Danovitch G.M., Ament M.E., Memsic L.D. Liver transplantation today. Ann Intern Med. 104:1986;377-389
11. Wicomb W.N., Cooper D.K., Lanza R.P., Novitzky D., Isaacs S. The effects of brain death and 24 hours' storage by hypothermic perfusion on donor heart function in the pig. J Thorac Cardiovasc Surg. 91:1986;896-909
12. Pennefather S.H., Bullock R.E., Dark J.H. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation. 56:1993;1418-1422
13. McElhinney D.B., Khan J.H., Babcock W.D., Hall T.S. Thoracic organ donor characteristics associated with successful lung procurement. Clin Transplant. 15:2001;68-71
14. Zaroff J.G., Babcock W.D., Shiboski S.C. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant. 22:2003;334-337
15. Ware L.B., Fang X., Wang Y., Sakuma T., Hall T.S., Matthay M.A. Selected contribution mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol. 93:2002;1869-1874
16. Katz K., Lawler J., Wax J., O'Connor R., Nadkarni V. Vasopressin pressor effects in critically ill children during evaluation for brain death and organ recovery. Resuscitation. 47:2000;33-40
17. Pennefather S.H., Bullock R.E., Mantle D., Dark J.H. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation. 59:1995;58-62
18. Iwai A., Sakano T., Uenishi M., Sugimoto H., Yoshioka T., Sugimoto T. Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation. 48:1989;613-617
19. Chen J.M., Cullinane S., Spanier T.B., et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation. 100:(suppl 19):1999;II244-II246
20. Gramm H.J., Meinhold H., Bickel U., et al. Acute endocrine failure after brain death? Transplantation. 54:1992;851-857
21. Howlett T.A., Keogh A.M., Perry L., Touzel R., Rees L.H. Anterior and posterior pituitary function in brain-stem-dead donors. A possible role for hormonal replacement therapy. Transplantation. 47:1989;828-834
22. Chen E.P., Bittner H.B., Kendall S.W., Van Trigt P. Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med. 24:1996;1352-1359
23. Wheeldon D.R., Potter C.D., Oduro A., Wallwork J., Large S.R. Transforming the "unacceptable" donor Outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant. 14:1995;734-742
24. Cooper D.K., Novitzky D., Wicomb W.N. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl. 71:1989;261-266
25. Follette D.M., Rudich S.M., Babcock W.D. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant. 17:1998;423-429
26. Powner D.J. Effects of gene induction and cytokine production in donor care. Progr Transplant. 13:2003;9-14
27. Washida M., Okamoto R., Manaka D., et al. Beneficial effect of combined 3,5,3′-triiodothyronine and vasopressin administration of hepatic energy status and systemic hemodynamics after brain death. Transplantation. 54:1992;44-49
28. Salim A., Vassiliu P., Velmahos G.C., et al. The role of thyroid hormone administration in potential organ donors. Arch Surg. 136:2001;1377-1380
29. Novitzky D., Cooper D.K., Chaffin J.S., Greer A.E., DeBault L.E., Zuhdi N. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation. 49:1990;311-316
30. Zaroff J.G., Rosengard B.R., Armstrong W.F., et al. Maximizing use of organs recovered from the cadaver donor Cardiac recommendations(1), march 28-29, 2001, crystal city, va. J Heart Lung Transplant. 21:2002;1153-1160
31. Palac R.T., Sumner G., Laird R., O'Rourke D.J. Reversible myocardial dysfunction after traumatic brain injury Mechanisms and implications for heart transplantation. Progr Transplant. 13:2003;42-46
32. Zaroff J.G., Babcock W.D., Shiboski S.C., Solinger L.L., Rosengard B.R. Temporal changes in left ventricular systolic function in heart donors Results of serial echocardiography. J Heart Lung Transplant. 22:2003;383-388
33. Riou B., Guesde R., Jacquens Y., Duranteau R., Viars P. Fiberoptic bronchoscopy in brain-dead organ donors. Am J Respir Crit Care Med. 150:1994;558-560
34. Pierre A.F., Sekine Y., Hutcheon M.A., Waddell T.K., Keshavjee S.H. Marginal donor lungs A reassessment. J Thorac Cardiovasc Surg. 123:2002;421-428
35. Dos Santos C.C., Slutsky A.S. Invited review Mechanisms of ventilator-induced lung injury: a perspective. J Appl Physiol. 89:2000;1645-1655
36. Puskas J.D., Winton T.L., Miller J.D., Scavuzzo M., Patterson G.A. Unilateral donor lung dysfunction does not preclude successful contralateral single lung transplantation. J Thorac Cardiovasc Surg. 103:1992;1015-1017
37. Braverman J.M. Increasing the quantity of lungs for transplantation using high-frequency chest wall oscillation A proposal. Progr Transplant. 12:2002;266-274
38. Babcock W.D., Menza R.L., Riznyk S., Prince P., Kern T.J. Results of a prospective study using high-frequency chest wall oscillation for brain dead organ donors. 2002;. Annual meeting of the International Society of Heart and Lung Transplantation, Washington, DC, April
39. Sundaresan S., Trachiotis G.D., Aoe M., Patterson G.A., Cooper J.D. Donor lung procurement Assessment and operative technique. Ann Thorac Surg. 56:1993;1409-1413
40. Bolton J.S., Padia S.A., Borja M.C., Becker P., Orens J.B., Wiener C., et al. The predictive value and inter-observer variability of donor chest radiograph interpretation in lung transplantation. Eur J Cardiothorac Surg. 23:2003;484-487
41. Sole-Violan J., Rodriguez D.C., Rey A., et al. Comparison of bronchoscopic diagnostic techniques with histological findings in brain dead organ donors without suspected pneumonia. Thorax. 51:1996;929-931
42. Hall T.S., Babcock W.D., Jablons D.M. Current lung donor indicators of infection are not reliable. 2002;. Annual International Conference on Lung Transplantation, Paris, France, September
43. Weill D., Dey G.C., Hicks R.A., Young K.R. Jr, et al. A positive donor gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant. 21:2002;555-558
44. Dowling R.D., Zenati M., Yousem S.A., et al. Donor-transmitted pneumonia in experimental lung allografts. Successful prevention with donor antibiotic therapy. J Thorac Cardiovasc Surg. 103:1992;767-772
45. Straznicka M., Follette D.M., Eisner M.D., Roberts P.F., Menza R.L., Babcock W.D. Aggressive management of lung donors classified as unacceptable Excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg. 124:2002;250-258